Visalytics
Visalytics
approved EB-2 (NIW)

Research Associate

Biological Sciences · Nepal · 2025-05-13

Processing Time
330 days
Decision Date
2025-05-13
Location
Virginia
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop targeted gene therapies for chronic pain management by investigating cellular and molecular mechanisms in the brain. The work focuses on studying specific neural circuits and epigenetic pathways, such as circular RNAs and allele-specific enhancers, to address the root causes of pain perception and provide safer alternatives to opioids.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses the U.S. chronic pain crisis which affects 51 million Americans and costs over $500 billion annually.

2 Well-positioned to Advance the Endeavor Met

The petitioner has a record of high-impact publications in top journals and has identified novel genetic disease pathways.

3 Balance of Interests Met

The urgent national need for non-opioid pain treatments and the petitioner's unique expertise make it beneficial to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 4 peer-reviewed journal articles and 15 citations, including work in top-tier journals like PLOS ONE. Expert testimony confirmed the national importance of the research in addressing the chronic pain crisis affecting 51 million Americans. The case satisfied all three Dhanasar prongs by demonstrating scientific innovation and a strong background in neuroscience.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Research and Development · South Korea

WeGreened EB-2 (NIW) approved
North Carolina 116 days 2022-10-08
The petitioner proposes to continue her research on identifying biomarkers and cognitive processes associated with chronic pain to develop improved monitoring and treatment methods. Her work focuses on the mechanisms of chronic pain and its effects on the body's reward center to create safer alternatives to opioids.
View Case

Associate Professor

Pharmaceuticals · Iran

WeGreened EB-2 (NIW) approved
119 days 2025-02-20
The petitioner proposes to design and apply innovative pharmaceutical agents as adjunctive therapies to conventional treatments for chronic neuropathic pain and mental health disorders. The work focuses on developing compounds with enhanced analgesic effects while minimizing dependency risks and investigating mechanisms to prevent morphine tolerance. Additionally, the endeavor aims to create targeted therapeutic approaches for depressive disorders with improved safety profiles.
View Case

Assistant Professor

Healthcare · Kuwait

WeGreened EB-2 (NIW) approved
Arizona 3 days 2024-01-25
The petitioner proposes to research and identify high-risk patients for challenging pain control before surgery to create tailored intervention and medication plans for hospitalization. This work aims to provide effective pain management across all phases of patient care, specifically focusing on improving outcomes for cancer survivors and patients undergoing renal resections.
View Case

Associate Professor

Pharmaceuticals · Pakistan

WeGreened EB-2 (NIW) approved
487 days 2025-04-15
The petitioner proposes to design natural compound-based therapeutics using computer-aided drug discovery to treat Type 1 diabetes and neurological disorders. This work focuses on developing non-synthetic therapeutic options for inflammation-related disorders, chronic pain, and systemic conditions using bioactive compounds from traditional medicinal plants. The endeavor aims to improve patient outcomes and address significant public health concerns in the United States.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Nepal

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-05-13.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 330 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Nepal All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist